Cidara Therapeutics, Inc. (CDTX) Financials

CDTX Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 63.5 million 55.4 million
2023-06-30 68.0 million 52.6 million
2023-03-31 81.7 million 54.9 million
2022-12-31 47.6 million 50.5 million

CDTX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -1.8 million 796000
2023-06-30 2.7 million 795000
2023-03-31 -11.0 million 640000
2022-12-31 -21.0 million 673000

CDTX Net Income

No data available :(

CDTX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 48.7 million - 4.4 million
2023-06-30 50.4 million - 4.5 million
2023-03-31 48.0 million - 1.0 million
2022-12-31 32.7 million - 1.3 million

CDTX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 90.3 million
2023-06-30 90.1 million
2023-03-31 101.2 million
2022-12-31 71.9 million

CDTX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 126000 17.3 million 3.6 million -
2023-06-30 107000 17.1 million 3.3 million -
2023-03-31 94000 18.7 million 4.3 million -
2022-12-31 9000 20.1 million 3.4 million -

CDTX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 12.7 million 387000
2023-06-30 7.6 million 401000
2023-03-31 26.0 million 320000
2022-12-31 10.2 million 29000

CDTX

Price: $12.51

52 week price:
0.51
13.00

Earnings Per Share: -0.39 USD

P/E Ratio: -1.87

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 3.0 million

Ebitda: -12.1 million

Market Capitalization: 66.2 million

Links: